Alzheimer Inserm VCDN

2000

Brevets/Patents

Publications

Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Tau isoforms in neurodegenerative disorders. Brain Res Rev 33: 95-130.
Delacourte A. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 54, 538.
Delacourte A and Buee L. Tau pathology: a marker of neurodegenerative disorders. Current Opinion in Neurology, 13: 371-376
Delacourte A. Histoire naturelle et moléculaire de la maladie d'Alzheimer. Ann Biol Clin, 2000, 58:350-355
Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen SH, Dickson DW. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy: a brainstorming conference. Acta Neuropathologica 2000, 15:446-458.
Ledesma MD Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG. Brain Plasmin influences APP alpha cleavage and Abeta Degradation and is Reduced in Alzheimer's Disease Brains. EMBO Reports. 61:1-6
Litvan I, Dickson D.W, Buttner-Ennever J.A, Delacourte A et al. Research goals in progressive supranuclear palsy and Pick's disease Mov Disord 20: 543-549.
Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buée L. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2000;100:235-244.
Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet-Boudin ML, Delacourte A, Buée L. Pathological tau phenotypes: the weight of mutations, polymorphisms and differential neuronal vulnerabilities. Ann NY Acad Sci 920: 107-114.
Ferreira S, Dupire MJ, Delacourte A, Najib J, Caillet-Boudin ML.Synthesis, and regulation of apolipoprotein E during the differentiation of human neuronal precursore NT2/D1 cells into post-mitotic neurons. Exp. Neurol. 166:415-421

See also: A disastrous case of cleavage

PUBLICATION DANS DES OUVRAGES

Buée L, Mailliot C, Bussière T, Sergeant N, Buée-Scherrer V, Hof PR, Flament S, Delacourte A. Neurodegenerative disorders with tauopathies: Mad tau diseases? Research and Perspectives in Alzheimer's disease. Editors: Lee VM, Trojanowski JQ, Buee L, Christen Y. pp. 105-125.
Buée L et Delacourte A. Les isoformes de tau: marqueurs pathologiques. Traité de Neurologie. Editions Douin. Sous presse.
Delacourte A et Buée L. Les marqueurs de la maladie d'Alzheimer. Traité de Neurologie. Editions Douin. Sous presse.
Delacourte A. Physiopathologie de la maladie d'Alzheimer. Encyclopédie MédicoChirurgicale

Delacourte A. The molecular parameters of tau pathology in Neuropathology and genetics of dementia. Edited by Joanna Lawrence, Kluwer Academic/plenum.
Delacourte A et David JP. Modèle cellulaire du vieillissement cérébral; Monographies du Groupe de recherche sur la maladie d'Alzheimer. Attention la mémoire. JF Camus, MC Gély-Nargeot, BF Michel eds. Solal Editeur Marseille - 2000. Pages 65-75.
Delacourte A. Des neurones pris entre deux feux. Dans "Les performances de la mémoires humaine. Science et Vie. Hors série. 2000, 212: 120-124
Leys D, Masson C, Buée L Cerebral amyloid angiopathies. In : Stroke Syndrome. Eds Bogousslavsky J, Caplan L. sous presse
Lee VM, Trojanowski JQ, Buée L, Christen Y: Edition de l'ouvrage Research and Perspectives in Alzheimer's disease.

Communications sur invitation

Buée L " Pathological tau phenotypes: the weight of mutations, polymorphisms and differential neuronal vulnerabilities ". Ninth meeting of the international study group on the pharmacology of memory disorders associated with aging, Zürich, Suisse, 18-20 février 2000.
Buée L, Delacourte A. "Aspects physiopathologiques des démences dégénératives" Interface INSERM-Société Française de Neurologie, Journées de Neurologie de Langue Française, Montpellier, 12-15 avril 2000.
Delacourte A. Amyloidopathy versus tauopathy. The Luigi Amaducci Dementia teachnig course. EFNS Copenhagen 14-19 Octobre 2000
The biology and pathogenesis of tau in different types of dementia. Belgian Neurologists meeting. September 23^rd 2000. Leuven. Belgique.
Delacourte A. Tau isoform expression in neurodegenerative disorders. Invitation au World Alzheimer Congress 2000, Juillet 9-18, Washington DC.
Delacourte A. Séminaire sur invitation. "Neuropathology and genetics of dementia". XVIIIth winter meeting of the Swiss Society of Neuropathology, St Moritz Switzerland. Mars

Sergeant , Delacourte A. Biochemical definintion of tau pathologies. First International Neuroscience Symposium. Barcelona. March 2^nd 2000.

Thèse

Christel Mailliot (22 mai 2000) La phosphorylation des isoformes de protéines tau. Univ. Lille I.

Publications VCDN
2000 Brevets/Patents Publications Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Tau isoforms in neurodegenerative disorders. Brain Res Rev 33: 95-130. Delacourte A. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 54, 538. Delacourte A and Buee L. Tau pathology: a marker of neurodegenerative disorders. Current Opinion in Neurology, 13: 371-376 Delacourte A. Histoire naturelle et moléculaire de la maladie d'Alzheimer. Ann Biol Clin, 2000, 58:350-355 Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen SH, Dickson DW. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy: a brainstorming conference. Acta Neuropathologica 2000, 15:446-458. Ledesma MD Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG. Brain Plasmin influences APP alpha cleavage and Abeta Degradation and is Reduced in Alzheimer's Disease Brains. EMBO Reports. 61:1-6 Litvan I, Dickson D.W, Buttner-Ennever J.A, Delacourte A et al. Research goals in progressive supranuclear palsy and Pick's disease Mov Disord 20: 543-549. Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buée L. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2000;100:235-244. Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet-Boudin ML, Delacourte A, Buée L. Pathological tau phenotypes: the weight of mutations, polymorphisms and differential neuronal vulnerabilities. Ann NY Acad Sci 920: 107-114. Ferreira S, Dupire MJ, Delacourte A, Najib J, Caillet-Boudin ML.Synthesis, and regulation of apolipoprotein E during the differentiation of human neuronal precursore NT2/D1 cells into post-mitotic neurons. Exp. Neurol. 166:415-421 See also: A disastrous case of cleavage PUBLICATION DANS DES OUVRAGES Buée L, Mailliot C, Bussière T, Sergeant N, Buée-Scherrer V, Hof PR, Flament S, Delacourte A. Neurodegenerative disorders with tauopathies: Mad tau diseases? Research and Perspectives in Alzheimer's disease. Editors: Lee VM, Trojanowski JQ, Buee L, Christen Y. pp. 105-125. Buée L et Delacourte A. Les isoformes de tau: marqueurs pathologiques. Traité de Neurologie. Editions Douin. Sous presse. Delacourte A et Buée L. Les marqueurs de la maladie d'Alzheimer. Traité de Neurologie. Editions Douin. Sous presse. Delacourte A. Physiopathologie de la maladie d'Alzheimer. Encyclopédie MédicoChirurgicale Delacourte A. The molecular parameters of tau pathology in Neuropathology and genetics of dementia. Edited by Joanna Lawrence, Kluwer Academic/plenum. Delacourte A et David JP. Modèle cellulaire du vieillissement cérébral; Monographies du Groupe de recherche sur la maladie d'Alzheimer. Attention la mémoire. JF Camus, MC Gély-Nargeot, BF Michel eds. Solal Editeur Marseille - 2000. Pages 65-75. Delacourte A. Des neurones pris entre deux feux. Dans "Les performances de la mémoires humaine. Science et Vie. Hors série. 2000, 212: 120-124 Leys D, Masson C, Buée L Cerebral amyloid angiopathies. In : Stroke Syndrome. Eds Bogousslavsky J, Caplan L. sous presse Lee VM, Trojanowski JQ, Buée L, Christen Y: Edition de l'ouvrage Research and Perspectives in Alzheimer's disease. Communications sur invitation Buée L " Pathological tau phenotypes: the weight of mutations, polymorphisms and differential neuronal vulnerabilities ". Ninth meeting of the international study group on the pharmacology of memory disorders associated with aging, Zürich, Suisse, 18-20 février 2000. Buée L, Delacourte A. "Aspects physiopathologiques des démences dégénératives" Interface INSERM-Société Française de Neurologie, Journées de Neurologie de Langue Française, Montpellier, 12-15 avril 2000. Delacourte A. Amyloidopathy versus tauopathy. The Luigi Amaducci Dementia teachnig course. EFNS Copenhagen 14-19 Octobre 2000 The biology and pathogenesis of tau in different types of dementia. Belgian Neurologists meeting. September 23^rd 2000. Leuven. Belgique. Delacourte A. Tau isoform expression in neurodegenerative disorders. Invitation au World Alzheimer Congress 2000, Juillet 9-18, Washington DC. Delacourte A. Séminaire sur invitation. "Neuropathology and genetics of dementia". XVIIIth winter meeting of the Swiss Society of Neuropathology, St Moritz Switzerland. Mars Sergeant , Delacourte A. Biochemical definintion of tau pathologies. First International Neuroscience Symposium. Barcelona. March 2^nd 2000. Thèse Christel Mailliot (22 mai 2000) La phosphorylation des isoformes de protéines tau. Univ. Lille I.